Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1383 entries
Sorted by: Best Match Show Resources per page
Time‐limited buprenorphine replacement therapy for opioid dependence: 2‐year follow‐up outcomes in relation to programme completion and current agonist therapy …

community settings

[No authors listed]
GSID: cUmrTDd8l0EJ
H Kornør, H Waal, L Sandvik - Drug and alcohol review, 2007 - Wiley Online Library

Programme completion is predictive of post‐treatment abstinence and other improvements in persons with opioid dependence, while continued agonist treatment is associated with …

Cite
Kornør, H., Kornør, H., Waal, H., Kornør, H., Waal, H., Sandvik, L., ... & Sandvik, L. (2007). Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status. Drug and alcohol review, 26(2), 135-141.
Kornør, Hege, et al. "Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status." Drug and alcohol review 26.2 (2007): 135-141.
Copy Download .nbib Format: MLA
Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial

community settings

Lintzeris N, Ritter A, Clark N.
GSID: VG-OBdXK8SAJ
N Lintzeris, A Ritter, M Panjari, N Clark… - … American Journal on …, 2004 - Wiley Online Library

… An underlying goal of the study was to have a set of guidelines suited to community settings that could be readily disseminated for widespread use following the registration of buprenorphine. The initial BIT guidelines were developed by Turning...

Cite
Lintzeris, Nicholas, et al. "Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial." The American Journal on Addictions 13.S1 (2004): S29-S41.
Lintzeris N. et al. Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial //The American Journal on Addictions. – 2004. – Т. 13. – №. S1. – С. S29-S41.
Copy Download .nbib Format: MLA
Post-treatment outcomes of buprenorphine detoxification in community settings: a systematic review

community settings

Armitage CJ.
GSID: 2qWrmImgxWwJ
MJ Horspool, N Seivewright, CJ Armitage… - European addiction …, 2008 - karger.com

… Inpatient settings have better completion rates than community settings, but heroin cessation rates are generally low … communitybased and general practitioners are increasingly becoming involved in drug treatment, this review focuses on clinical trials conducted in these settings…

Cite
Horspool, M. J., Seivewright, N., Armitage, C. J., & Mathers, N. (2008). Post-treatment outcomes of buprenorphine detoxification in community settings: a systematic review. European addiction research, 14(4), 179-185.
Horspool, Michelle J., et al. "Post-treatment outcomes of buprenorphine detoxification in community settings: a systematic review." European addiction research 14.4 (2008): 179-185.
Copy Download .nbib Format: MLA
Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19

Latinx/Hispanic ethnicity

Samuels EA, Khatri UG, Snyder H.
GSID: fUz0u52zPDoJ
EA Samuels, UG Khatri, H Snyder… - Journal of general …, 2022 - Springer

… has shown that individuals who are Black, Latinx/Hispanic, older, lower income, and female … existing inequities in treatment access by geography, race, and income. Longer-term …

Cite
Samuels, E. A., Khatri, U. G., Snyder, H., Wightman, R. S., Tofighi, B., & Krawczyk, N. (2022). Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19. Journal of general internal medicine, 1-3.
Samuels, Elizabeth A., et al. "Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19." Journal of general internal medicine (2022): 1-3.
Copy Download .nbib Format: MLA
A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial

community settings

[No authors listed]
GSID: qKxsvJCLyiAJ
D Raistrick, D West, O Finnegan, G Thistlethwaite… - …, 2005 - Wiley Online Library

Objective To investigate whether a buprenorphine opiate detoxification regimen can be considered to be at least as clinically effective as a lofexidine regimen. Design An open …

Cite
Raistrick, D., West, D., Finnegan, O., Thistlethwaite, G., Brearley, R., & Banbery, J. (2005). A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial. Addiction, 100(12), 1860-1867.
Raistrick, Duncan, et al. "A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial." Addiction 100.12 (2005): 1860-1867.
Copy Download .nbib Format: MLA
Using the mouse grimace scale and behaviour to assess pain in CBA mice following vasectomy.

Applied animal behaviour science

Miller AL, Kitson GL, Skalkoyannis B, Flecknell PA, Leach MC.
PMID: 27499567
Appl Anim Behav Sci. 2016 Aug;181:160-165. doi: 10.1016/j.applanim.2016.05.020.

Mice used in biomedical research should have pain reduced to an absolute minimum through refinement of procedures or by the provision of appropriate analgesia. Vasectomy is a common and potentially painful surgical procedure carried out on male mice to...

Cite
Miller AL, Kitson GL, Skalkoyannis B, et al. Using the mouse grimace scale and behaviour to assess pain in CBA mice following vasectomy. Appl Anim Behav Sci. 2016;181:160-165doi: 10.1016/j.applanim.2016.05.020.
Miller, A. L., Kitson, G. L., Skalkoyannis, B., Flecknell, P. A., & Leach, M. C. (2016). Using the mouse grimace scale and behaviour to assess pain in CBA mice following vasectomy. Applied animal behaviour science, 181160-165. https://doi.org/10.1016/j.applanim.2016.05.020
Miller, Amy L, et al. "Using the mouse grimace scale and behaviour to assess pain in CBA mice following vasectomy." Applied animal behaviour science vol. 181 (2016): 160-165. doi: https://doi.org/10.1016/j.applanim.2016.05.020
Miller AL, Kitson GL, Skalkoyannis B, Flecknell PA, Leach MC. Using the mouse grimace scale and behaviour to assess pain in CBA mice following vasectomy. Appl Anim Behav Sci. 2016 Aug;181:160-165. doi: 10.1016/j.applanim.2016.05.020. PMID: 27499567; PMCID: PMC4962773.
Copy Download .nbib Format: NLM
Target controlled priming for rapid onset of intubation dose: A new approach.

Journal of anesthesia

Tripathi M, Singh PK, Ambesh SP, Kaushik S.
PMID: 28921062
J Anesth. 1997 Dec;11(4):255-259. doi: 10.1007/BF02480740.

PURPOSE: To determine the pattern of onset of the intubating dose when given at a monitored target priming block in either phase of the priming drug effect.METHODS: Sixty consenting ASA I and II patients were premedicated by intramuscular buprenorphine...

Cite
Tripathi M, Singh PK, Ambesh SP, et al. Target controlled priming for rapid onset of intubation dose: A new approach. J Anesth. 1997;11(4):255-259doi: 10.1007/BF02480740.
Tripathi, M., Singh, P. K., Ambesh, S. P., & Kaushik, S. (1997). Target controlled priming for rapid onset of intubation dose: A new approach. Journal of anesthesia, 11(4), 255-259. https://doi.org/10.1007/BF02480740
Tripathi, Mukesh, et al. "Target controlled priming for rapid onset of intubation dose: A new approach." Journal of anesthesia vol. 11,4 (1997): 255-259. doi: https://doi.org/10.1007/BF02480740
Tripathi M, Singh PK, Ambesh SP, Kaushik S. Target controlled priming for rapid onset of intubation dose: A new approach. J Anesth. 1997 Dec;11(4):255-259. doi: 10.1007/BF02480740. PMID: 28921062.
Copy Download .nbib Format: NLM
Intrathecal buprenorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries.

Journal of anaesthesiology, clinical pharmacology

Singh AP, Kaur R, Gupta R, Kumari A.
PMID: 27275055
J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):229-33. doi: 10.4103/0970-9185.182107.

BACKGROUND AND AIMS: This study aims to compare the anesthesia characteristics between buprenorphine and fentanyl when added as an adjuvant to intrathecal ropivaciane in an attempt to prolong the duration of spinal anesthesia.MATERIAL AND METHODS: The present prospective double-blind...

Cite
Singh AP, Kaur R, Gupta R, et al. Intrathecal buprenorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries. J Anaesthesiol Clin Pharmacol. 2016;32(2):229-33doi: 10.4103/0970-9185.182107.
Singh, A. P., Kaur, R., Gupta, R., & Kumari, A. (2016). Intrathecal buprenorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries. Journal of anaesthesiology, clinical pharmacology, 32(2), 229-33. https://doi.org/10.4103/0970-9185.182107
Singh, Arvinder Pal, et al. "Intrathecal buprenorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries." Journal of anaesthesiology, clinical pharmacology vol. 32,2 (2016): 229-33. doi: https://doi.org/10.4103/0970-9185.182107
Singh AP, Kaur R, Gupta R, Kumari A. Intrathecal buprenorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):229-33. doi: 10.4103/0970-9185.182107. PMID: 27275055; PMCID: PMC4874080.
Copy Download .nbib Format: NLM
New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.

Substance abuse and rehabilitation

Soyka M.
PMID: 25610012
Subst Abuse Rehabil. 2015 Jan 06;6:1-14. doi: 10.2147/SAR.S45585. eCollection 2015.

Opioid maintenance therapy is a well-established first-line treatment approach in opioid dependence. Buprenorphine, a partial opioid agonist, has been found by numerous studies to be an effective and safe medication in the treatment of opioid dependence. At present, buprenorphine...

Cite
Soyka M. New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. Subst Abuse Rehabil. 2015;6:1-14doi: 10.2147/SAR.S45585.
Soyka, M. (2015). New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. Substance abuse and rehabilitation, 61-14. https://doi.org/10.2147/SAR.S45585
Soyka, Michael. "New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone." Substance abuse and rehabilitation vol. 6 (2015): 1-14. doi: https://doi.org/10.2147/SAR.S45585
Soyka M. New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. Subst Abuse Rehabil. 2015 Jan 06;6:1-14. doi: 10.2147/SAR.S45585. eCollection 2015. PMID: 25610012; PMCID: PMC4293937.
Copy Download .nbib Format: NLM
Adherence to Buprenorphine Maintenance Treatment in Opioid Dependence Syndrome: A Case Control Study.

Indian journal of psychological medicine

Bandawar M, Kandasamy A, Chand P, Murthy P, Benegal V.
PMID: 26664083
Indian J Psychol Med. 2015 Jul-Sep;37(3):330-2. doi: 10.4103/0253-7176.162951.

BACKGROUND: Opioid Use disorders are emerging as a serious public health concern in India. Opioid substitution treatment is one of the emerging forms of treatment in this population which needs more evidence to increase its availability and address prejudices...

Cite
Bandawar M, Kandasamy A, Chand P, et al. Adherence to Buprenorphine Maintenance Treatment in Opioid Dependence Syndrome: A Case Control Study. Indian J Psychol Med. 2015;37(3):330-2doi: 10.4103/0253-7176.162951.
Bandawar, M., Kandasamy, A., Chand, P., Murthy, P., & Benegal, V. (2015). Adherence to Buprenorphine Maintenance Treatment in Opioid Dependence Syndrome: A Case Control Study. Indian journal of psychological medicine, 37(3), 330-2. https://doi.org/10.4103/0253-7176.162951
Bandawar, Mrunal, et al. "Adherence to Buprenorphine Maintenance Treatment in Opioid Dependence Syndrome: A Case Control Study." Indian journal of psychological medicine vol. 37,3 (2015): 330-2. doi: https://doi.org/10.4103/0253-7176.162951
Bandawar M, Kandasamy A, Chand P, Murthy P, Benegal V. Adherence to Buprenorphine Maintenance Treatment in Opioid Dependence Syndrome: A Case Control Study. Indian J Psychol Med. 2015 Jul-Sep;37(3):330-2. doi: 10.4103/0253-7176.162951. PMID: 26664083; PMCID: PMC4649800.
Copy Download .nbib Format: NLM
Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study.

Journal of clinical and diagnostic research : JCDR

Hussain SS, Farhat S, Rather YH, Abbas Z.
PMID: 25738001
J Clin Diagn Res. 2015 Jan;9(1):FC01-4. doi: 10.7860/JCDR/2015/10625.5425. Epub 2015 Jan 01.

OBJECTIVES: Prevalence of opioid addiction has alarmingly increased over the recent years. In South Asian region alone there are more than 10 million opioid abusers amounting to 2% of world population. Detoxification remains to be the first step for...

Cite
Hussain SS, Farhat S, Rather YH, et al. Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study. J Clin Diagn Res. 2015;9(1):FC01-4doi: 10.7860/JCDR/2015/10625.5425.
Hussain, S. S., Farhat, S., Rather, Y. H., & Abbas, Z. (2015). Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study. Journal of clinical and diagnostic research : JCDR, 9(1), FC01-4. https://doi.org/10.7860/JCDR/2015/10625.5425
Hussain, Syed Sajad, et al. "Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study." Journal of clinical and diagnostic research : JCDR vol. 9,1 (2015): FC01-4. doi: https://doi.org/10.7860/JCDR/2015/10625.5425
Hussain SS, Farhat S, Rather YH, Abbas Z. Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study. J Clin Diagn Res. 2015 Jan;9(1):FC01-4. doi: 10.7860/JCDR/2015/10625.5425. Epub 2015 Jan 01. PMID: 25738001; PMCID: PMC4347092.
Copy Download .nbib Format: NLM
Buprenorphine waivers: the authors reply.

Health affairs (Project Hope)

Stein BD, Gordon AJ, Dick AW.
PMID: 26240259
Health Aff (Millwood). 2015 Aug;34(8):1428. doi: 10.1377/hlthaff.2015.0766.

No abstract available.

Cite
Stein BD, Gordon AJ, Dick AW. Buprenorphine waivers: the authors reply. Health Aff (Millwood). 2015;34(8):1428doi: 10.1377/hlthaff.2015.0766.
Stein, B. D., Gordon, A. J., & Dick, A. W. (2015). Buprenorphine waivers: the authors reply. Health affairs (Project Hope), 34(8), 1428. https://doi.org/10.1377/hlthaff.2015.0766
Stein, Bradley D, et al. "Buprenorphine waivers: the authors reply." Health affairs (Project Hope) vol. 34,8 (2015): 1428. doi: https://doi.org/10.1377/hlthaff.2015.0766
Stein BD, Gordon AJ, Dick AW. Buprenorphine waivers: the authors reply. Health Aff (Millwood). 2015 Aug;34(8):1428. doi: 10.1377/hlthaff.2015.0766. PMID: 26240259.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1383 entries